Partner Content Partner Content 4 KEY QUESTIONS IN NEW EXPERIMENTAL TECHNOLOGIES ANSWERED Drug Discovery Conference
Novartis Novartis adds Promacta to breakthrough status roll-call Drug could get new indication based on NIH research
News Novartis taking aim at Pfizer with new use for breast cancer... FDA grants Breakthrough Therapy for Kisqali in premenopausal women.
News NHS funding for five MS drugs under threat NICE calls for further discounts on beta-interferons and Copaxone
News Pfizer's Ibrance available across UK after thumbs up in Scot... Around 800 women have received the drug for free.
News Ipsen' Bylvay fluffs its lines in biliary atresia trial Ipsen's IBAT inhibitor Bylvay has failed a trial in biliary atresia, a rare and serious liver disease that affects babies and has limited treatments.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
